13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q1 2024 · Filed April 22, 2024 · Accession 0001213900-24-034979
Total Value
$1.27B
Positions
42
Other Managers
0
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 8,418,093 | $360.3M | 28.31% |
| 2 | Geron Corp | GERN | 27,225,292 | $89.8M | 7.06% |
| 3 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $87.5M | 6.88% |
| 4 | Sinovac Biotech Ltd. | SVA | 11,800,000 | $76.3M | 6.00% |
| 5 | Avadel Pharmaceuticals PLC | 05337M104 | 3,972,099 | $67.1M | 5.27% |
| 6 | Verona Pharma PLC | 925050106 | 3,610,177 | $58.1M | 4.56% |
| 7 | ALX Oncology Holdings Inc | ALXO | 4,220,048 | $47.1M | 3.70% |
| 8 | Dyne Therapeutics Inc | DYN | 1,635,136 | $46.4M | 3.65% |
| 9 | Terns Pharmaceuticals Inc | TERN | 6,657,992 | $43.7M | 3.43% |
| 10 | Astria Therapeutics Inc | 04635X102 | 2,329,027 | $32.8M | 2.58% |
| 11 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $29.4M | 2.31% |
| 12 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $23.9M | 1.88% |
| 13 | Olema Pharmaceuticals Inc | OLMA | 1,873,704 | $21.2M | 1.67% |
| 14 | Adverum Biotechnologies, Inc. | 00773U207 | 1,500,000 | $21.2M | 1.67% |
| 15 | Alpine Immune Sciences Inc | 02083G100 | 520,505 | $20.8M | 1.63% |
| 16 | Tarsus Pharmaceuticals Inc | TARS | 565,550 | $20.6M | 1.62% |
| 17 | Verastem Inc | VSTM | 1,538,461 | $18.2M | 1.43% |
| 18 | Crinetics Pharmaceuticals Inc | CRNX | 350,000 | $16.4M | 1.29% |
| 19 | Cogent Biosciences Inc | COGT | 2,244,941 | $15.1M | 1.19% |
| 20 | Sera Prognostics Inc | SERA | 1,650,440 | $15.0M | 1.18% |
| 21 | Regulus Therapeutics Inc | 75915K309 | 5,000,000 | $14.4M | 1.13% |
| 22 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $13.6M | 1.07% |
| 23 | Compass Pathway PLC | CMPS | 1,608,000 | $13.4M | 1.05% |
| 24 | Oric Pharmaceuticals Inc | ORIC | 849,681 | $11.7M | 0.92% |
| 25 | Engene Holdings Inc. | ENGNW | 678,705 | $11.5M | 0.90% |
| 26 | Genetron Holdings Ltd | 37186H209 | 2,708,056 | $10.9M | 0.86% |
| 27 | IO Biotech Inc | IOBT | 6,173,439 | $10.7M | 0.84% |
| 28 | Savara Inc | SVRA | 2,088,323 | $10.4M | 0.82% |
| 29 | Zai Lab Ltd | ZLAB | 531,198 | $8.5M | 0.67% |
| 30 | Delcath Systems, Inc. | DCTH | 1,666,746 | $8.0M | 0.62% |
| 31 | Rezolute Inc | RZLT | 2,797,704 | $7.1M | 0.56% |
| 32 | Compass Therapeutics Inc | CMPX | 3,556,023 | $7.0M | 0.55% |
| 33 | Instil Bio Inc | TIL | 624,338 | $6.7M | 0.53% |
| 34 | Q32 Bio Inc. | QTTB | 370,068 | $6.3M | 0.50% |
| 35 | Bolt Therapeutics Inc | BOLT | 3,521,291 | $4.9M | 0.39% |
| 36 | Unicycive Therapeutics | UNCY | 3,470,152 | $4.8M | 0.38% |
| 37 | Allakos Inc | 01671P100 | 2,988,000 | $3.8M | 0.30% |
| 38 | Aligos Therapeutics Inc | ALGS | 3,547,030 | $3.5M | 0.27% |
| 39 | DBV Technologies SA | DBVTF | 2,708,875 | $2.0M | 0.16% |
| 40 | Codexis, Inc | CDXS | 388,144 | $1.4M | 0.11% |
| 41 | Aadi Bioscience Inc | WHWK | 509,572 | $1.2M | 0.09% |
| 42 | Precision Biosciences Inc | DTIL | 4,675 | $63,395 | 0.00% |